Smith Craig J, Bray Benjamin D, Hoffman Alex, Meisel Andreas, Heuschmann Peter U, Wolfe Charles D A, Tyrrell Pippa J, Rudd Anthony G
Stroke and Vascular Research Centre, Institute of Cardiovascular Sciences, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK (C.J.S., P.J.T.) Greater Manchester Comprehensive Stroke Centre, Department of Medical Neurosciences, Salford Royal NHS Foundation Trust, Salford, UK (C.J.S., P.J.T.).
Division of Health and Social Care Research, King's College London, UK (B.D.B., C.A.W., A.G.R.).
J Am Heart Assoc. 2015 Jan 13;4(1):e001307. doi: 10.1161/JAHA.114.001307.
Pneumonia frequently complicates stroke and has a major impact on outcome. We derived and internally validated a simple clinical risk score for predicting stroke-associated pneumonia (SAP), and compared the performance with an existing score (A(2)DS(2)).
We extracted data for patients with ischemic stroke or intracerebral hemorrhage from the Sentinel Stroke National Audit Programme multicenter UK registry. The data were randomly allocated into derivation (n=11 551) and validation (n=11 648) samples. A multivariable logistic regression model was fitted to the derivation data to predict SAP in the first 7 days of admission. The characteristics of the score were evaluated using receiver operating characteristics (discrimination) and by plotting predicted versus observed SAP frequency in deciles of risk (calibration). Prevalence of SAP was 6.7% overall. The final 22-point score (ISAN: prestroke Independence [modified Rankin scale], Sex, Age, National Institutes of Health Stroke Scale) exhibited good discrimination in the ischemic stroke derivation (C-statistic 0.79; 95% CI 0.77 to 0.81) and validation (C-statistic 0.78; 95% CI 0.76 to 0.80) samples. It was well calibrated in ischemic stroke and was further classified into meaningful risk groups (low 0 to 5, medium 6 to 10, high 11 to 14, and very high ≥15) associated with SAP frequencies of 1.6%, 4.9%, 12.6%, and 26.4%, respectively, in the validation sample. Discrimination for both scores was similar, although they performed less well in the intracerebral hemorrhage patients with an apparent ceiling effect.
The ISAN score is a simple tool for predicting SAP in clinical practice. External validation is required in ischemic and hemorrhagic stroke cohorts.
肺炎常使卒中病情复杂化,并对预后产生重大影响。我们推导并在内部验证了一个用于预测卒中相关性肺炎(SAP)的简单临床风险评分,并将其性能与现有评分(A(2)DS(2))进行比较。
我们从英国卒中哨兵国家审计计划多中心登记处提取了缺血性卒中和脑出血患者的数据。数据被随机分配到推导样本(n = 11551)和验证样本(n = 11648)中。采用多变量逻辑回归模型对推导数据进行拟合,以预测入院后前7天内的SAP。使用受试者工作特征曲线(辨别力)以及通过绘制风险十分位数中预测的与观察到的SAP频率(校准)来评估该评分的特征。总体SAP患病率为6.7%。最终的22分评分(ISAN:卒中前独立性[改良Rankin量表]、性别、年龄、美国国立卫生研究院卒中量表)在缺血性卒中推导样本(C统计量0.79;95% CI 0.77至0.81)和验证样本(C统计量0.78;95% CI 0.76至0.80)中表现出良好的辨别力。它在缺血性卒中中校准良好,并进一步分为与验证样本中SAP频率分别为1.6%、4.9%、12.6%和26.4%相关的有意义的风险组(低0至5分、中6至1分、高11至14分、非常高≥15分)。两种评分的辨别力相似,尽管它们在脑出血患者中表现较差,存在明显的天花板效应。
ISAN评分是临床实践中预测SAP的一个简单工具。需要在缺血性和出血性卒中队列中进行外部验证。